ArticleScientific reports2025
The association of HIF1A gene polymorphism and its expression with ischemic stroke.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Hypoxia-inducible factor 1 A (HIF1A) is considered as a potential marker gene for ischemic stroke (IS), its gene polymorphism may affect IS risk and may be related to the IS pathological process. In this study, a total of 159 IS patients and 141 healthy controls were enrolled by case-control study method. HIF1A three single nucleotide polymorphisms (SNPs: rs10873142, rs11549465, rs11549467) were genotyped by SNaPshot method and HIF1A protein levels was detected by enzyme-linked immunosorbent assay (ELISA), then the correlation between HIF-1 A SNPs and IS was analyzed by statistical analysis method. The genotype of HIF1A SNPs can affect the expression levels of clinical and laboratory parameters in IS patients, such as high-density lipoproteincholesterol (HDL-C), apolipoprotein A1, reactive oxygen species (ROS). HIF1A TCG haplotype is a protective factor for IS, HIF1A CCG haplotype is a risk factor for IS. However, the association between HIF1A rs10873142, rs11549465, rs11549467 genotypes and the IS risk was not statistically significant. ELISA analysis showed that the HIF1A expression of IS patients is higher than the healthy controls. Therefore, the gene polymorphism and expression of HIF1A may be related to IS pathological process, but the relationship between HIF1A gene polymorphism and the IS risk still needs further study.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.